Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Sidney Keisner

Concepts (49)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Bone Density Conservation Agents
2
2023
75
0.810
Why?
Bone Neoplasms
2
2023
188
0.740
Why?
Phenylthiohydantoin
1
2016
2
0.490
Why?
Warfarin
1
2016
81
0.450
Why?
Thrombosis
1
2016
250
0.400
Why?
Anticoagulants
1
2016
280
0.390
Why?
Ketoconazole
1
2010
10
0.330
Why?
Androgen Antagonists
1
2010
13
0.320
Why?
Carcinoma, Renal Cell
1
2011
112
0.310
Why?
Sulfonamides
1
2011
139
0.300
Why?
Proton Pump Inhibitors
1
2010
95
0.300
Why?
Pyrimidines
1
2011
206
0.300
Why?
Kidney Neoplasms
1
2011
181
0.300
Why?
Protein Kinase Inhibitors
1
2011
234
0.290
Why?
Antineoplastic Agents
1
2016
1232
0.270
Why?
Prostatic Neoplasms
1
2010
401
0.250
Why?
Drug Interactions
2
2016
196
0.190
Why?
Phthalazines
1
2022
20
0.180
Why?
Piperazines
1
2022
125
0.170
Why?
Indoles
1
2022
280
0.150
Why?
Prospective Studies
1
2023
2412
0.130
Why?
Retrospective Studies
3
2023
6821
0.130
Why?
Benzamides
1
2016
52
0.120
Why?
Nitriles
1
2016
55
0.120
Why?
Humans
6
2023
53246
0.110
Why?
Male
4
2022
27444
0.100
Why?
Controlled Clinical Trials as Topic
1
2011
21
0.080
Why?
Clinical Trials, Phase III as Topic
1
2011
48
0.080
Why?
Indazoles
1
2011
47
0.080
Why?
Prostate-Specific Antigen
1
2010
43
0.080
Why?
Drug Resistance
1
2010
71
0.080
Why?
Treatment Outcome
2
2011
5597
0.080
Why?
Imidazoles
1
2011
114
0.080
Why?
Diphosphonates
1
2011
92
0.080
Why?
Middle Aged
3
2016
13422
0.080
Why?
Disease-Free Survival
1
2010
466
0.070
Why?
Gastrointestinal Diseases
1
2010
130
0.070
Why?
Drug Therapy, Combination
1
2010
405
0.070
Why?
Aged, 80 and over
2
2011
3495
0.060
Why?
Acute Kidney Injury
1
2011
400
0.060
Why?
Aged
2
2011
10430
0.040
Why?
Animals
1
2011
13528
0.030
Why?
Creatinine
1
2011
158
0.020
Why?
Incidence
1
2011
1085
0.020
Why?
Dose-Response Relationship, Drug
1
2011
1367
0.020
Why?
Time Factors
1
2011
2992
0.010
Why?
Neoplasms
1
2011
1335
0.010
Why?
Adult
1
2011
14541
0.010
Why?
Female
1
2011
28792
0.000
Why?
Keisner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Similar People Expand Description
_
Same Department Expand Description